Dubai clinic’s new genetic testing boosts IVF success with safer, non-invasive method
niPGT screens embryo DNA without biopsy or invasive procedures
DUBAI: Orchid Fertility, located in Dubai Healthcare City and part of Waha Health, is revolutionising the world of reproductive medicine by offering Non-Invasive Preimplantation Genetic Testing (niPGT).
This advanced screening method provides a safer alternative to traditional embryo biopsies, marking a significant milestone in fertility care across the United Arab Emirates.
With IVF becoming increasingly common, the need to select the healthiest embryos without risking their viability is more critical than ever. Traditional Preimplantation Genetic Testing (PGT) involves removing a few cells from an embryo – a biopsy that, while effective, introduces a degree of risk and stress to the embryo. Now, Orchid Fertility is offering a cutting-edge solution that analyses genetic material without touching the embryo itself.
Non-invasive breakthrough
“Through the use of Non-Invasive Preimplantation Genetic Testing, we can analyse an embryo's genetic composition without the need for a biopsy,” said Dr Dimitrios Kafetzis, Medical Director at Orchid Fertility. “This technology bypasses any risk, thereby allowing us to give our patients peace of mind and still provide information on their embryos.”
The niPGT technique relies on studying free DNA that the embryo naturally releases into its surrounding culture medium. This method enables fertility specialists to detect chromosomal abnormalities without harming the embryo’s structural integrity – making it a particularly suitable option for women over 35 and those who have experienced multiple failed IVF cycles due to unexplained implantation failure.
Comprehensive genetic services
Orchid Fertility’s comprehensive suite of genetic testing services includes:
- PGT-A (Aneuploidy): Screens for chromosomal disorders such as Down syndrome.
- PGT-M (Monogenic): Detects specific inherited disorders like sickle cell anaemia and cystic fibrosis.
- PGT-SR (Structural Rearrangements): Identifies translocations and other chromosomal structural issues.
- Carrier Screening: Assesses both partners for the risk of passing on inherited conditions.
“Selecting the most suitable embryo for implantation has long been an important aspect of in vitro fertilisation; and we are always looking for a less invasive alternative to PGT-A,” added Dr Kafetzis. While niPGT is not a full replacement for PGT-A, it serves as a powerful initial screening tool that enhances embryo selection when used in conjunction with other technologies such as next-generation embryoscopes.
Personalised fertility care
Beyond technology, Orchid Fertility offers a holistic approach to fertility. The clinic integrates medical, emotional, and lifestyle support into its patient care plans. This includes attention to diet, mental well-being, and stress reduction, ensuring each couple’s journey is fully supported from consultation to conception.
Orchid Fertility adheres to rigorous international clinical standards and delivers compassionate, evidence-based care to couples seeking fertility solutions. Its team of specialists is trained in the latest techniques and remains committed to improving success rates while safeguarding embryo health.
Couples across the UAE can now benefit from these advances without the emotional and physical toll that traditional genetic testing may bring.